Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Osteoarthritic Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
PainOsteoarthritis
Interventions
DRUG

Placebo

Corresponding placebo is applied for 12weeks

DRUG

Buprenorphine Transdermal System

Buprenorphine Transdermal System 5, 10 or 20mg/patch is applied for 12weeks

Trial Locations (28)

Unknown

Investigational Site, Nagoya

Investigational Site, Okazaki

Investigational Site, Ichikawa

Investigational Site, Matsudo

Investigational Site, Nagareyama

Investigational Site, Fukui-shi

Investigational Site, Annaka

Investigational Site, Takasaki

Investigational Site, Chitose

Investigational Site, Sapporo

Investigational Site, Kako

Investigational Site, Kobe

Investigational Site, Yokohama

Investigational Site, Jōyō

Investigational Site, Sendai

Investigational Site, Isahaya

Investigational Site, Osaka

Investigational Site, Kasukabe

Investigational Site, Koshigaya

Investigational Site, Hikone

Investigational Site, Adachi City

Investigational Site, Arakawa City

Investigational Site, Edogawa City

Investigational Site, Koto

Investigational Site, Setagaya City

Investigational Site, Suginami

Investigational Site, Himi

Investigational Site, Kurobe-shi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mundipharma K.K.

INDUSTRY